日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Predominance of genomically defined A lineage of HPV16 over D lineage in Indian patients from eastern India with squamous cell carcinoma of the cervix in association with distinct oncogenic phenotypes

印度东部患有宫颈鳞状细胞癌的印度患者中,基因组定义的HPV16 A谱系比D谱系占优势,并伴有不同的致癌表型。

Mandal, Paramita; Bhattacharjee, Bornali; Sen, Shrinka; Bhattacharya, Amrapali; Saha, Sweta Sharma; Chowdhury, Rahul Roy; Mondal, Nidhu Ranjan; Chakrabarty, Biman; Chatterjee, Tanmay; Roy, Sudipta; Sengupta, Sharmila

Cervical cancer subtypes harbouring integrated and/or episomal HPV16 portray distinct molecular phenotypes based on transcriptome profiling of mRNAs and miRNAs

根据mRNA和miRNA的转录组分析,携带整合型和/或游离型HPV16的宫颈癌亚型表现出不同的分子表型。

Mandal, Paramita; Saha, Sweta Sharma; Sen, Shrinka; Bhattacharya, Amrapali; Bhattacharya, Nitai P; Bucha, Sudha; Sinha, Mithun; Chowdhury, Rahul Roy; Mondal, Nidhu Ranjan; Chakravarty, Biman; Chatterjee, Tanmay; Roy, Sudipta; Chattapadhyay, Ansuman; Sengupta, Sharmila

The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis.

与癌症相关的、功能获得性 TP53 变体 P152Lp53 激活了与肿瘤发生有关的多个信号通路

Singh Siddharth, Kumar Manoj, Kumar Sanjeev, Sen Shrinka, Upadhyay Pawan, Bhattacharjee Sayan, M Naveen, Tomar Vivek Singh, Roy Siddhartha, Dutt Amit, Kundu Tapas K

Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a

染色质蛋白PC4在乳腺癌中表达下调,促进疾病进展:miR-29a的作用

Sikder, Sweta; Kumari, Sujata; Kumar, Manoj; Sen, Shrinka; Singhal, Namrata Bora; Chellappan, Srikumar; Godbole, Mukul; Chandrani, Pratik; Dutt, Amit; Gopinath, Kodaganur S; Kundu, Tapas K